The White House has pulled Dr. Heidi Overton's nomination to lead the Food and Drug Administration, a White House official confirmed on Tuesday, a day before the Senate Health, Education, Labor and Pensions (HELP) Committee was scheduled to vote on whether to advance her nomination. The move was first reported by Axios.
Overton, a physician and deputy director of the White House Domestic Policy Council, needed the support of every Republican on the 21-member committee to advance, with Democrats expected to oppose her. Republicans hold 12 seats to the Democrats' 11, so a single Republican defection would have sunk the nomination. Committee chairman Senator Bill Cassidy, a Louisiana doctor, had said earlier in the day that he remained undecided, and Senators Susan Collins of Maine and Lisa Murkowski of Alaska had not said how they would vote.
Overton faced bipartisan questions about her willingness to break from President Donald Trump, particularly on his unsupported claims about the dangers of childhood vaccines. Senators also pressed her on her support for breaking up combination vaccines — including the measles, mumps and rubella shot — her stance on abortion policy, including oversight of the abortion pill mifepristone, and her role in loosening restrictions on vapes. Her confirmation hearing in September was contentious.
Trump nominated Overton in August, tapping a White House policy aide who had previously worked at the America First Policy Institute to lead an agency that has faced controversies over vaccines, drug approvals and abortion-related policy. The nomination followed the departure of former FDA Commissioner Marty Makary in May. The agency has been led on an acting basis by attorney Kyle Diamantas.
The withdrawal leaves the administration searching for a new leader for the FDA, a key health agency overseeing prescription drugs, vaccines, medical devices and food safety. Health Secretary Robert F. Kennedy Jr. has reached out to Senator Roger Marshall of Kansas about taking the job, according to the Wall Street Journal, and Marshall is reportedly being considered as a possible replacement. The White House has previously pulled several other health nominations.



